
pmid: 8503009
A nonpeptidyl secretagogue for growth hormone of the structure 3-amino-3-methyl-N-(2,3,4,5-tetrahydro-2-oxo-1-{[2′-(1H-tetrazol-5-yl) (1,1′-biphenyl)-4-yl]methyl}-1H-1-benzazepin-3(R)-yl)-butanamide (L-692,429) has been identified. L-692,429 synergizes with the natural growth hormone secretagogue growth hormone-releasing hormone and acts through an alternative signal transduction pathway. The mechanism of action of L-692,429 and studies with peptidyl and nonpeptidyl antagonists suggest that this molecule is a mimic of the growth hormone-releasing hexapeptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2(GHRP-6). L-692,429 is an example of a nonpeptidyl specific secretagogue for growth hormone.
Male, Molecular Sequence Data, Tetrazoles, Stereoisomerism, Benzazepines, Second Messenger Systems, Membrane Potentials, Rats, Structure-Activity Relationship, Dogs, Pituitary Gland, Anterior, Growth Hormone, Animals, Amino Acid Sequence, Oligopeptides, Cells, Cultured
Male, Molecular Sequence Data, Tetrazoles, Stereoisomerism, Benzazepines, Second Messenger Systems, Membrane Potentials, Rats, Structure-Activity Relationship, Dogs, Pituitary Gland, Anterior, Growth Hormone, Animals, Amino Acid Sequence, Oligopeptides, Cells, Cultured
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 372 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 0.1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
